Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Monoamine Oxidase Inhibitors (therapeutic use) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Monoamine Oxidase Inhibitors (pharmacology) < Monoamine Oxidase Inhibitors (therapeutic use) < Monoamine metabolism  Facettes :

List of bibliographic references indexed by Monoamine Oxidase Inhibitors (therapeutic use)

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000213 (2015) Oscar S. Gershanik [Argentine]Improving L-dopa therapy: the development of enzyme inhibitors.
000558 (2014) Elisabeth B. Lucassen [États-Unis] ; Nicholas W. Sterling [États-Unis] ; Eun-Young Lee [États-Unis] ; Honglei Chen [États-Unis] ; Mechelle M. Lewis [États-Unis] ; Lan Kong [États-Unis] ; Xuemei Huang [États-Unis]History of smoking and olfaction in Parkinson’s disease
001667 (2011) Peter Jenner [Royaume-Uni] ; J. William Langston [États-Unis]Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline
001A16 (2010) Stuart H. Isaacson [États-Unis]Selective MAO‐B inhibitors have low potential for the tyramine effect
002096 (2009) Rosalind S. Chuang [Canada] ; Anthony E. Lang [Canada]Rasagiline‐induced spontaneous ejaculation
002186 (2009) Robert G. Hart [États-Unis] ; Lesly A. Pearce [États-Unis] ; Bernard M. Ravina [États-Unis] ; Toby C. Yaltho [États-Unis] ; John R. Marler [États-Unis]Neuroprotection trials in Parkinson's disease: Systematic review
002557 (2008) Fabrizio Stocchi [Italie] ; Michele Tagliati [États-Unis] ; C. Warren Olanow [États-Unis]Treatment of levodopa‐induced motor complications
002657 (2008) Francisco Coria [Espagne] ; María Del Puig Cozar-Santiago [Espagne]Rasagiline improves freezing in a patient with primary progressive freezing gait
002771 (2008) Nir Giladi [Israël]Medical treatment of freezing of gait
002E36 (2007) Anthony H. V. Schapira [Royaume-Uni]Future directions in the treatment of Parkinson's disease
003811 (2005) Cheryl Waters [États-Unis]Other pharmacological treatments for motor complications and dyskinesias
003924 (2005) Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal]Evidence‐based medical review update: Pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004
003B74 (2004) Marcin Ach [Pologne] ; Andrzej Friedman [Pologne] ; Jarosław Sławek [Pologne] ; Mirosława Derejko [Pologne]Quality of life in Polish patients with long‐lasting Parkinson's disease
003D36 (2004) Matthew B. Stern [États-Unis] ; Kenneth L. Marek [États-Unis] ; Joseph Friedman [États-Unis] ; Robert A. Hauser [États-Unis] ; Peter A. Lewitt [États-Unis] ; Daniel Tarsy [États-Unis] ; C. Warren Olanow [États-Unis]Double‐blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients
003E24 (2004) Susan Hollán [Hongrie] ; Lászl Vécsei [Hongrie] ; Kálmán Magyar [Hongrie]Adverse effects of dopamine potentiation by long‐term treatment with selegiline
004396 (2002) MAO‐B inhibitors for the treatment of Parkinson's disease
004F03 (1998) Andreas Kupsch [Allemagne] ; Oertel [Allemagne]Selegiline, pregnancy, and Parkinson's disease
005259 (1997) Lyytinen [Finlande] ; Seppo Kaakkola [Finlande] ; Sirpa Ahtila [Finlande] ; P Ivi Tuomainen [Finlande] ; Heikki Ter V Inen [Finlande]Simultaneous MAO‐B and COMT inhibition in L‐dopa‐treated patients with parkinson's disease
005890 (1995) Oertel [Allemagne] ; R. C. Dodel [Allemagne]International guide to drugs for Parkinson's disease
005D67 (1993) M. E. Giuffra [États-Unis] ; V. H. Sethy [États-Unis] ; T. L. Davis [États-Unis] ; M. M. Mouradian [États-Unis] ; Chase [États-Unis]Milacemide therapy for Parkinson's disease
005E40 (1993) M. B. H. Youdim [Israël] ; P. RiedererThe relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Monoamine Oxidase Inhibitors (therapeutic use)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Monoamine Oxidase Inhibitors (therapeutic use)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Monoamine Oxidase Inhibitors (therapeutic use)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024